Expression and clinical significance of NLRC5 in hepatocellular carcinoma
NLRC5, the largest member of the nucleotide-binding and oligomerization domain (NOD)-like receptor (NLR) family, has been reported to participate in the regulation of immune function and is associated with chronic inflammatory diseases. However, the biological function of NLRC5 in hepatocellular car...
Saved in:
| Main Authors: | Xiangyu Ma, Shangkun Ning, Tong Sun, Mei Liu, Jibing Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Cancer Biology & Therapy |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/15384047.2024.2390205 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cancer-associated fibroblasts in hepatocellular carcinoma: origins, heterogeneity, and therapeutic implications
by: Xin Shi, et al.
Published: (2025-07-01) -
Metabolic reprogramming in hepatocellular carcinoma: mechanisms of immune evasion and therapeutic implications
by: Bocheng Gao, et al.
Published: (2025-04-01) -
Targeting NLRC4 for potential therapeutic strategies in lung adenocarcinoma
by: Xue Xu, et al.
Published: (2025-06-01) -
Emerging insights into the gut microbiota as a key regulator of immunity and response to immunotherapy in hepatocellular carcinoma
by: Siqi Ren, et al.
Published: (2025-02-01) -
Clinical significance and expression of SLC35F6 in bladder urothelial carcinoma
by: Jinling Zhang, et al.
Published: (2024-11-01)